A risk model for prolonged air leak after lobectomy using the National Clinical Database in Japan

Surgery Today ◽  
2021 ◽  
Author(s):  
Yasushi Shintani ◽  
Hiroyuki Yamamoto ◽  
Yukio Sato ◽  
Kimihiro Shimizu ◽  
Shunsuke Endo ◽  
...  
2013 ◽  
Vol 49 (6) ◽  
pp. 1047-1055 ◽  
Author(s):  
Hirotoshi Kobayashi ◽  
Hiroaki Miyata ◽  
Mitsukazu Gotoh ◽  
Hideo Baba ◽  
Wataru Kimura ◽  
...  

2019 ◽  
Vol 108 (5) ◽  
pp. 1478-1483 ◽  
Author(s):  
Christopher W. Seder ◽  
Sanjib Basu ◽  
Timothy Ramsay ◽  
Gaetano Rocco ◽  
Shanda Blackmon ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (11) ◽  
pp. e0187598 ◽  
Author(s):  
Won Ho Kim ◽  
Hyung-Chul Lee ◽  
Ho-Geol Ryu ◽  
Hyun-Kyu Yoon ◽  
Chul-Woo Jung

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Eitan Podgaetz ◽  
Felix Zamora ◽  
Heidi Gibson ◽  
Rafael S. Andrade ◽  
Eric Hall ◽  
...  

Background.Prolonged air leak is defined as an ongoing air leak for more than 5 days. Intrabronchial valve (IBV) treatment is approved for the treatment of air leaks.Objective.To analyze our experience with IBV and valuate its cost-effectiveness.Methods.Retrospective analysis of IBV from June 2013 to October 2014. We analyzed direct costs based on hospital and operating room charges. We used average costs in US dollars for the analysis not individual patient data.Results.We treated 13 patients (9 M/4 F), median age of 60 years (38 to 90). Median time from diagnosis to IBV placement was 9.8 days, time from IBV placement to chest tube removal was 3 days, and time from IBV placement to hospital discharge was 4 days. Average room and board costs were $14,605 including all levels of care. IBV cost is $2750 per valve. The average number of valves used was 4. Total cost of procedure, valves, and hospital stay until discharge was $13,900.Conclusion.In our limited experience, the use of IBV to treat prolonged air leaks is safe and appears cost-effective. In pure financial terms, the cost seems justified for any air leak predicted to last greater than 8 days.


2021 ◽  
Vol 28 (4) ◽  
pp. 305-316
Author(s):  
Itaru Endo ◽  
Norimichi Hirahara ◽  
Hiroaki Miyata ◽  
Hiroyuki Yamamoto ◽  
Ryusei Matsuyama ◽  
...  

Author(s):  
Alessio Campisi ◽  
Andrea Dell'Amore ◽  
Yonghui Zhang ◽  
Zhitao Gu ◽  
Angelo Paolo Ciarrocchi ◽  
...  

Abstract Background Air leak is the most common complication after lung resection and leads to increased length of hospital (LOH) stay or patient discharge with a chest tube. Management by autologous blood patch pleurodesis (ABPP) is controversial because few studies exist, and the technique has yet to be standardized. Methods We retrospectively reviewed patients undergoing ABPP for prolonged air leak (PAL) following lobectomy in three centers, between January 2014 and December 2019. They were divided into two groups: Group A, 120 mL of blood infused; Group B, 60 mL. Propensity score-matched (PSM) analysis was performed, and 23 patients were included in each group. Numbers and success rates of blood patch, time to cessation of air leak, time to chest tube removal, reoperation, LOH, and complications were examined. Univariate and multivariate analysis of variables associated with an increased risk of air leak was performed. Results After the PSM, 120 mL of blood is statistically significant in reducing the number of days before chest tube removal after ABPP (2.78 vs. 4.35), LOH after ABPP (3.78 vs. 10.00), and LOH (8.78 vs. 15.17). Complications (0 vs. 4) and hours until air leak cessation (6.83 vs. 3.91, range 1–13) after ABPP were also statistically different (p < 0.05). Air leaks that persisted for up to 13 hours required another ABPP. No patient had re-operation or long-term complications related to pleurodesis. Conclusion In our experience, 120 mL is the optimal amount of blood and the procedure can be repeated every 24 hours with the chest tube clamped.


2016 ◽  
Vol 21 (1) ◽  
pp. 27-35
Author(s):  
Hiraku KUMAMARU ◽  
Arata TAKAHASHI ◽  
Eriko FUKUCHI ◽  
Naoaki ICHIHARA ◽  
Norimichi HIRAHARA ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Lars Dinjens ◽  
Wytze S. de Boer ◽  
Jos A. Stigt

Surgery Today ◽  
2017 ◽  
Vol 47 (8) ◽  
pp. 973-979 ◽  
Author(s):  
Satoru Okada ◽  
Junichi Shimada ◽  
Daishiro Kato ◽  
Hiroaki Tsunezuka ◽  
Masayoshi Inoue

Sign in / Sign up

Export Citation Format

Share Document